Monash University, Melbourne, VIC.
Victorian Assisted Reproductive Treatment Authority, Melbourne, VIC.
Med J Aust. 2020 Nov;213(10):458-464. doi: 10.5694/mja2.50831. Epub 2020 Oct 26.
To estimate the population prevalence of clinically significant symptoms of depression, generalised anxiety, thoughts of being better off dead, irritability, and high optimism about the future, and of direct experience of COVID-19, loss of employment caused by COVID-19 restrictions, worry about contracting COVID-19, or major disadvantage because of the restrictions; to examine the relationship between these experiences and reporting mental symptoms.
DESIGN, SETTING, PARTICIPANTS: Anonymous online survey of adult Australian residents, 3 April - 2 May 2020.
Self-reported psychological status during the preceding fortnight assessed with the Patient Health Questionnaire 9 (PHQ-9; symptoms of depression) and the Generalised Anxiety Disorder Scale (GAD-7). Optimism about the future was assessed with a 10-point study-specific visual analogue scale.
13 829 respondents contributed complete response data. The estimated prevalence of clinically significant symptoms of depression (PHQ-9 ≥ 10) was 27.6% (95% CI, 26.1-29.1%) and of clinically significant symptoms of anxiety (GAD-7 ≥ 10) 21.0% (95% CI, 19.6-22.4%); 14.6% of respondents (95% CI, 13.5-16.0%) reported thoughts of being better off dead or self-harm (PHQ-9, item 9) on at least some days and 59.2% (95% CI, 57.6-60.7%) that they were more irritable (GAD-7, item 6). An estimated 28.3% of respondents (95% CI, 27.1-29.6%) reported great optimism about the future (score ≥ 8). People who had lost jobs, were worried about contracting COVID-19, or for whom the restrictions had a highly adverse impact on daily life were more likely to report symptoms of depression or anxiety, and less likely to report high optimism than people without these experiences.
Mental health problems were widespread among Australians during the first month of the stage two COVID-19 restrictions; in addition, about one-quarter of respondents reported mild to moderate symptoms of depression or anxiety. A public mental health response that includes universal, selective and indicated clinical interventions is needed.
估计患有临床显著抑郁症状、广泛性焦虑、有寻死念头、易怒和对未来高度乐观、直接经历过 COVID-19、因 COVID-19 限制而失业、担心感染 COVID-19 或因限制而遭受重大不利影响的人群的流行率;调查这些经历与报告精神症状之间的关系。
设计、地点、参与者:2020 年 4 月 3 日至 5 月 2 日期间,对澳大利亚成年居民进行匿名在线调查。
采用患者健康问卷 9(PHQ-9;抑郁症状)和广泛性焦虑症量表(GAD-7)评估过去两周的自我报告心理状况。对未来的乐观程度采用 10 分制的特定研究视觉模拟量表进行评估。
13829 名受访者提供了完整的应答数据。临床显著抑郁症状(PHQ-9≥10)的估计患病率为 27.6%(95%CI,26.1-29.1%),临床显著焦虑症状(GAD-7≥10)的估计患病率为 21.0%(95%CI,19.6-22.4%);14.6%的受访者(95%CI,13.5-16.0%)报告至少在某些日子里有寻死或自残的念头(PHQ-9,第 9 项),59.2%(95%CI,57.6-60.7%)的受访者报告更易怒(GAD-7,第 6 项)。估计有 28.3%的受访者(95%CI,27.1-29.6%)对未来高度乐观(得分≥8)。失去工作、担心感染 COVID-19 或限制对日常生活产生严重不利影响的人更有可能报告抑郁或焦虑症状,而不太可能报告高度乐观,而没有这些经历的人则报告较少。
在 COVID-19 限制的第二阶段开始后的第一个月,澳大利亚民众的心理健康问题普遍存在;此外,约四分之一的受访者报告有轻度至中度抑郁或焦虑症状。需要采取包括普遍、选择性和针对性临床干预的公共心理健康应对措施。